Bashar Mohammed Thejer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bashar Mohammed Thejer has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Michael A. Cahill
School of Dentistry and Medical Sciences, Charles Sturt University, Wagga Wagga, NSW 2678, Australia
4 shared publications - Sarah Teakel
Charles Sturt University
4 shared publications - Hans Neubauer
Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Düsseldorf, Germany
3 shared publications - Marina Ludescher
Department of Gynecology and Obstetrics, University Women's Hospital of Düsseldorf, Düsseldorf, Germany
3 shared publications - Elizabeth J. New
School of Chemistry, The University of Sydney, NSW 2006, Australia
2 shared publications - Ewa M. Goldys
Graduate School of Biomedical Engineering, ARC Centre of Excellence for Nanoscale BioPhotonics, University of New South Wales , Sydney, NSW
2 shared publications
Latest Publications
- 19 October 2026
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 27, 1-13
A Sustainable Approach for Antioxidant and Anti- Diabetic Activity of Green Synthesis Iron Oxide Nanoparticles Using Pomegranate Peels Extract
Introduction/Objective: Pomegranate peel, an agricultural waste material, is a rich source of various bioactive compounds, including flavonoids, phenols, and anthocyanins, possessing significant antioxidant properties. The study was designed to utilize pomegranate peel extract for the eco-friendly synthesis of iron oxide nanoparticles (Fe₃O₄ NPs) and to investigate their antioxidant, anti-diabetic activity, and cytotoxic potential. Methods: Fe₃O₄ NPs were ecofriendly synthesized and fully characterized using UV-Vis spectroscopy, FTIR, EDX, XRD, and SEM. Additionally, their antioxidant activity was evaluated using the DPPH Radical Scavenging Assay. Antidiabetic activity was assessed using the α- amylase inhibition assay, α-glucosidase inhibitory assay, and glucose uptake assay. Cytotoxicity was assessed via the hemolysis potential assay. The concentrations of prepared Fe₃O₄ NPs and positive controls used in the experiments were chosen depending on preliminary pilot experiments to find dose-dependent curves and precisely calculate IC50 values at non-toxic levels according to literature guidelines. Results: Fe₃O₄ NPs were found to exhibit excellent antioxidant activity, with an IC50 of 8.50 μg/mL, compared with 18.91 μg/mL for Vitamin C. Fe₃O₄ nanoparticles displayed significantly higher efficiency than metformin against alpha-amylase; the IC₅₀ value of Fe₃O₄ nanoparticles was 89.30 μg/mL compared to 150.11 μg/mL for metformin. The IC50 value of Fe3O4 NPs was 133.31 μg/mL against α-glucosidase. Moreover, Fe3O4 nanoparticles significantly increased glucose uptake in yeast cells, with an IC50 of 113.32 μg/mL, compared to metformin, which had an IC50 of 223.24 μg/mL. The hemolysis assay confirmed no significant cytotoxic effect. Discussion: NPs displayed a spherical shape with an average size of 61.4 nm. Clustering of particles was observed, which is likely due to the presence of phenolic compounds from Pomegranate Peel Extract (PPE) that act as reducing and capping agents. The presence of these compounds in the peel extract might be responsible for their antioxidant properties due to their ability to behave as capping agents and to improve the reactivity of Fe3O4 NPs to DPPH free radicals. Moreover, these nanoparticles are also effective in regulating α-amylase and α-glucosidase activity; the strong inhibition of these two enzymes could be due to interactions between Fe₃O₄ NPs and the active sites of each enzyme, whereas improved glucose uptake may be related to interactions with glucose transporters or increased membrane permeability. Conclusion: The green-synthesized iron oxide nanoparticles using pomegranate peel extract exhibit potent antioxidant and anti-diabetic activity with minimal cytotoxicity, highlighting their potential as eco-friendly therapeutic agents.
- 19 October 2026
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 27, 1-13
A Sustainable Approach for Antioxidant and Anti- Diabetic Activity of Green Synthesis Iron Oxide Nanoparticles Using Pomegranate Peels Extract
Introduction/Objective: Pomegranate peel, an agricultural waste material, is a rich source of various bioactive compounds, including flavonoids, phenols, and anthocyanins, possessing significant antioxidant properties. The study was designed to utilize pomegranate peel extract for the eco-friendly synthesis of iron oxide nanoparticles (Fe₃O₄ NPs) and to investigate their antioxidant, anti-diabetic activity, and cytotoxic potential. Methods: Fe₃O₄ NPs were ecofriendly synthesized and fully characterized using UV-Vis spectroscopy, FTIR, EDX, XRD, and SEM. Additionally, their antioxidant activity was evaluated using the DPPH Radical Scavenging Assay. Antidiabetic activity was assessed using the α- amylase inhibition assay, α-glucosidase inhibitory assay, and glucose uptake assay. Cytotoxicity was assessed via the hemolysis potential assay. The concentrations of prepared Fe₃O₄ NPs and positive controls used in the experiments were chosen depending on preliminary pilot experiments to find dose-dependent curves and precisely calculate IC50 values at non-toxic levels according to literature guidelines. Results: Fe₃O₄ NPs were found to exhibit excellent antioxidant activity, with an IC50 of 8.50 μg/mL, compared with 18.91 μg/mL for Vitamin C. Fe₃O₄ nanoparticles displayed significantly higher efficiency than metformin against alpha-amylase; the IC₅₀ value of Fe₃O₄ nanoparticles was 89.30 μg/mL compared to 150.11 μg/mL for metformin. The IC50 value of Fe3O4 NPs was 133.31 μg/mL against α-glucosidase. Moreover, Fe3O4 nanoparticles significantly increased glucose uptake in yeast cells, with an IC50 of 113.32 μg/mL, compared to metformin, which had an IC50 of 223.24 μg/mL. The hemolysis assay confirmed no significant cytotoxic effect. Discussion: NPs displayed a spherical shape with an average size of 61.4 nm. Clustering of particles was observed, which is likely due to the presence of phenolic compounds from Pomegranate Peel Extract (PPE) that act as reducing and capping agents. The presence of these compounds in the peel extract might be responsible for their antioxidant properties due to their ability to behave as capping agents and to improve the reactivity of Fe3O4 NPs to DPPH free radicals. Moreover, these nanoparticles are also effective in regulating α-amylase and α-glucosidase activity; the strong inhibition of these two enzymes could be due to interactions between Fe₃O₄ NPs and the active sites of each enzyme, whereas improved glucose uptake may be related to interactions with glucose transporters or increased membrane permeability. Conclusion: The green-synthesized iron oxide nanoparticles using pomegranate peel extract exhibit potent antioxidant and anti-diabetic activity with minimal cytotoxicity, highlighting their potential as eco-friendly therapeutic agents.
- Open Access
- 28 March 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (7) , 6381
Sigma-2 Receptor Ligand Binding Modulates Association between TSPO and TMEM97
Sigma-2 receptor (S2R) is a S2R ligand-binding site historically associated with reportedly 21.5 kDa proteins that have been linked to several diseases, such as cancer, Alzheimer’s disease, and schizophrenia. The S2R is highly expressed in various tumors, where it correlates with the proliferative status of the malignant cells. Recently, S2R was reported to be the transmembrane protein TMEM97. Prior to that, we had been investigating the translocator protein (TSPO) as a potential 21.5 kDa S2R candidate protein with reported heme and sterol associations. Here, we investigate the contributions of TMEM97 and TSPO to S2R activity in MCF7 breast adenocarcinoma and MIA PaCa-2 (MP) pancreatic carcinoma cells. Additionally, the role of the reported S2R-interacting partner PGRMC1 was also elucidated. Proximity ligation assays and co-immunoprecipitation show a functional association between S2R and TSPO. Moreover, a close physical colocalization of TMEM97 and TSPO was found in MP cells. In MCF7 cells, co-immunoprecipitation only occurred with TMEM97 but not with PGRMC1, which was further confirmed by confocal microscopy experiments. Treatment with the TMEM97 ligand 20-(S)-hydroxycholesterol reduced co-immunoprecipitation of both TMEM97 and PGRMC1 in immune pellets of immunoprecipitated TSPO in MP cells. To the best of our knowledge, this is the first suggestion of a (functional) interaction between TSPO and TMEM97 that can be affected by S2R ligands.
- 28 March 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (7) , 6381
Open AccessSigma-2 Receptor Ligand Binding Modulates Association between TSPO and TMEM97
Sigma-2 receptor (S2R) is a S2R ligand-binding site historically associated with reportedly 21.5 kDa proteins that have been linked to several diseases, such as cancer, Alzheimer’s disease, and schizophrenia. The S2R is highly expressed in various tumors, where it correlates with the proliferative status of the malignant cells. Recently, S2R was reported to be the transmembrane protein TMEM97. Prior to that, we had been investigating the translocator protein (TSPO) as a potential 21.5 kDa S2R candidate protein with reported heme and sterol associations. Here, we investigate the contributions of TMEM97 and TSPO to S2R activity in MCF7 breast adenocarcinoma and MIA PaCa-2 (MP) pancreatic carcinoma cells. Additionally, the role of the reported S2R-interacting partner PGRMC1 was also elucidated. Proximity ligation assays and co-immunoprecipitation show a functional association between S2R and TSPO. Moreover, a close physical colocalization of TMEM97 and TSPO was found in MP cells. In MCF7 cells, co-immunoprecipitation only occurred with TMEM97 but not with PGRMC1, which was further confirmed by confocal microscopy experiments. Treatment with the TMEM97 ligand 20-(S)-hydroxycholesterol reduced co-immunoprecipitation of both TMEM97 and PGRMC1 in immune pellets of immunoprecipitated TSPO in MP cells. To the best of our knowledge, this is the first suggestion of a (functional) interaction between TSPO and TMEM97 that can be affected by S2R ligands.
- Open Access
Neuroprotective Activity of Mentha Species on Hydrogen Peroxide-Induced Apoptosis in SH-SY5Y Cells
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder with an unclear cause. It appears that multiple factors participate in the process of neuronal damage including oxidative stress and accumulation of the protein amyloid β (Aβ) in the brain. The search for a treatment for this disorder is essential as current medications are limited to alleviating symptoms and palliative effects. The aim of this study is to investigate the effects of mint extracts on selected mechanisms implicated in the development of AD. To enable a thorough investigation of mechanisms, including effects on β-secretase (the enzyme that leads to the formation of Aβ), on Aβ aggregation, and on oxidative stress and apoptosis pathways, a neuronal cell model, SH-SY5Y cells, was selected. Six Mentha taxa were investigated for their in vitro β-secretase (BACE) and Aβ-aggregation inhibition activities. Moreover, their neuroprotective effects on H2O2-induced oxidative stress and apoptosis in SH-SY5Y cells were evaluated through caspase activity. Real-time PCR and Western blot analysis were carried out for the two most promising extracts to determine their effects on signalling pathways in SH-SY5Y cells. All mint extracts had strong BACE inhibition activity. M. requienii extracts showed excellent inhibition of Aβ-aggregation, while other extracts showed moderate inhibition. M. diemenica and M. requienii extracts lowered caspase activity. Exposure of SH-SY5Y cells to M. diemenica extracts resulted in a decrease in the expression of pro-apoptotic protein, Bax, and an elevation in the anti-apoptotic protein, Bcl-xL, potentially mediated by down-regulation of the ASK1-JNK pathway. These results indicate that mint extracts could prevent the formation of Aβ and also could prevent their aggregation if they had already formed. M. diemenica and M. requienii extracts have potential to suppress apoptosis at the cellular level. Hence, mint extracts could provide a source of efficacious compounds for a therapeutic approach for AD.
Open AccessNeuroprotective Activity of Mentha Species on Hydrogen Peroxide-Induced Apoptosis in SH-SY5Y Cells
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder with an unclear cause. It appears that multiple factors participate in the process of neuronal damage including oxidative stress and accumulation of the protein amyloid β (Aβ) in the brain. The search for a treatment for this disorder is essential as current medications are limited to alleviating symptoms and palliative effects. The aim of this study is to investigate the effects of mint extracts on selected mechanisms implicated in the development of AD. To enable a thorough investigation of mechanisms, including effects on β-secretase (the enzyme that leads to the formation of Aβ), on Aβ aggregation, and on oxidative stress and apoptosis pathways, a neuronal cell model, SH-SY5Y cells, was selected. Six Mentha taxa were investigated for their in vitro β-secretase (BACE) and Aβ-aggregation inhibition activities. Moreover, their neuroprotective effects on H2O2-induced oxidative stress and apoptosis in SH-SY5Y cells were evaluated through caspase activity. Real-time PCR and Western blot analysis were carried out for the two most promising extracts to determine their effects on signalling pathways in SH-SY5Y cells. All mint extracts had strong BACE inhibition activity. M. requienii extracts showed excellent inhibition of Aβ-aggregation, while other extracts showed moderate inhibition. M. diemenica and M. requienii extracts lowered caspase activity. Exposure of SH-SY5Y cells to M. diemenica extracts resulted in a decrease in the expression of pro-apoptotic protein, Bax, and an elevation in the anti-apoptotic protein, Bcl-xL, potentially mediated by down-regulation of the ASK1-JNK pathway. These results indicate that mint extracts could prevent the formation of Aβ and also could prevent their aggregation if they had already formed. M. diemenica and M. requienii extracts have potential to suppress apoptosis at the cellular level. Hence, mint extracts could provide a source of efficacious compounds for a therapeutic approach for AD.
- 1 March 2020
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 524 (1) , 64-69
Protein complexes including PGRMC1 and actin-associated proteins are disrupted by AG-205
- 1 March 2020
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 524 (1) , 64-69
Protein complexes including PGRMC1 and actin-associated proteins are disrupted by AG-205
- Open Access
PGRMC1 phosphorylation and cell plasticity 1: glycolysis, mitochondria, tumor growth
SUMMARY: Progesterone Receptor Membrane Component 1 (PGRMC1) is expressed in many cancer cells, where it is associated with detrimental patient outcomes. It contains phosphorylated tyrosines which evolutionarily preceded deuterostome gastrulation and tissue differentiation mechanisms. Here, we demonstrate that manipulating PGRMC1 phosphorylation status in MIA PaCa-2 (MP) cells imposes broad pleiotropic effects. Relative to parental cells over-expressing hemagglutinin-tagged wild-type (WT) PGRMC1-HA, cells expressing a PGRMC1-HA-S57A/S181A double mutant (DM) exhibited reduced levels of proteins involved in energy metabolism and mitochondrial function, and altered glucose metabolism suggesting modulation of the Warburg effect. This was associated with increased PI3K/Akt activity, altered cell shape, actin cytoskeleton, motility, and mitochondrial properties. An S57A/Y180F/S181A triple mutant (TM) indicated the involvement of Y180 in PI3K/Akt activation. Mutation of Y180F strongly attenuated mouse xenograft tumor growth. An accompanying paper demonstrates altered metabolism, mutation incidence, and epigenetic status in these cells, indicating that PGRMC1 phosphorylation strongly influences cancer biology.
Open AccessPGRMC1 phosphorylation and cell plasticity 1: glycolysis, mitochondria, tumor growth
SUMMARY: Progesterone Receptor Membrane Component 1 (PGRMC1) is expressed in many cancer cells, where it is associated with detrimental patient outcomes. It contains phosphorylated tyrosines which evolutionarily preceded deuterostome gastrulation and tissue differentiation mechanisms. Here, we demonstrate that manipulating PGRMC1 phosphorylation status in MIA PaCa-2 (MP) cells imposes broad pleiotropic effects. Relative to parental cells over-expressing hemagglutinin-tagged wild-type (WT) PGRMC1-HA, cells expressing a PGRMC1-HA-S57A/S181A double mutant (DM) exhibited reduced levels of proteins involved in energy metabolism and mitochondrial function, and altered glucose metabolism suggesting modulation of the Warburg effect. This was associated with increased PI3K/Akt activity, altered cell shape, actin cytoskeleton, motility, and mitochondrial properties. An S57A/Y180F/S181A triple mutant (TM) indicated the involvement of Y180 in PI3K/Akt activation. Mutation of Y180F strongly attenuated mouse xenograft tumor growth. An accompanying paper demonstrates altered metabolism, mutation incidence, and epigenetic status in these cells, indicating that PGRMC1 phosphorylation strongly influences cancer biology.
- Open Access
PGRMC1 phosphorylation and cell plasticity 2: genomic integrity and CpG methylation
SUMMARY: Progesterone receptor membrane component 1 (PGRMC1) is often elevated in cancers, and exists in alternative states of phosphorylation. A motif centered on PGRMC1 Y180 was evolutionarily acquired concurrently with the embryological gastrulation organizer that orchestrates vertebrate tissue differentiation. Here, we show that mutagenic manipulation of PGRMC1 phosphorylation alters cell metabolism, genomic stability, and CpG methylation. Each of several mutants elicited distinct patterns of genomic CpG methylation. Mutation of S57A/Y180/S181A led to increased net hypermethylation, reminiscent of embryonic stem cells. Pathways enrichment analysis suggested modulation of processes related to animal cell differentiation status and tissue identity, as well as cell cycle control and ATM/ATR DNA damage repair regulation. We detected different genomic mutation rates in culture. A companion manuscript shows that these cell states dramatically affect protein abundances, cell and mitochondrial morphology, and glycolytic metabolism. We propose that PGRMC1 phosphorylation status modulates cellular plasticity mechanisms relevant to early embryological tissue differentiation.
Open AccessPGRMC1 phosphorylation and cell plasticity 2: genomic integrity and CpG methylation
SUMMARY: Progesterone receptor membrane component 1 (PGRMC1) is often elevated in cancers, and exists in alternative states of phosphorylation. A motif centered on PGRMC1 Y180 was evolutionarily acquired concurrently with the embryological gastrulation organizer that orchestrates vertebrate tissue differentiation. Here, we show that mutagenic manipulation of PGRMC1 phosphorylation alters cell metabolism, genomic stability, and CpG methylation. Each of several mutants elicited distinct patterns of genomic CpG methylation. Mutation of S57A/Y180/S181A led to increased net hypermethylation, reminiscent of embryonic stem cells. Pathways enrichment analysis suggested modulation of processes related to animal cell differentiation status and tissue identity, as well as cell cycle control and ATM/ATR DNA damage repair regulation. We detected different genomic mutation rates in culture. A companion manuscript shows that these cell states dramatically affect protein abundances, cell and mitochondrial morphology, and glycolytic metabolism. We propose that PGRMC1 phosphorylation status modulates cellular plasticity mechanisms relevant to early embryological tissue differentiation.